These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1566403)

  • 21. Natural antibodies against bone marrow cells of a concordant xenogeneic species.
    Aksentijevich I; Sachs DH; Sykes M
    J Immunol; 1991 Jul; 147(1):79-85. PubMed ID: 2051029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of asialo GM1+, NK1.1- cells in the occurrence of graft-versus-host disease after total lymphoid irradiation.
    Waer M; Salam A; Vandeputte M
    Transplantation; 1993 Oct; 56(4):1049-51. PubMed ID: 8212193
    [No Abstract]   [Full Text] [Related]  

  • 24. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts.
    Moadsiri A; Polchert D; Genrich K; Napoles P; Reina E; Turian J; Smith B; Bartholomew A
    Surgery; 2006 Aug; 140(2):315-21. PubMed ID: 16904985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of preformed natural antibodies in preventing bone marrow engraftment in a discordant xenogeneic species combination (human-to-mouse).
    Kong SS; Ricordi C; Inverardi L
    Transplant Proc; 1997 Jun; 29(4):2069-70. PubMed ID: 9193531
    [No Abstract]   [Full Text] [Related]  

  • 27. Fully and long-term xenogeneic hematopoietic chimeras created in poorly concordant rat-mouse combinations: expression of hereditary donor characteristics.
    Spach C; Lucchiari N; Bureaud N; Motta R
    Exp Hematol; 1995 Oct; 23(11):1192-203. PubMed ID: 7556530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras.
    Zeng Y; Ildstad ST; Wren SM; Rilo HL; Bereiter DR; Carroll PB; Tzakis AG; Starzl TE; Ricordi C
    Transplant Proc; 1992 Jun; 24(3):985. PubMed ID: 1604698
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation.
    Waer M; Salam A; Vandeputte M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1281-2. PubMed ID: 8442112
    [No Abstract]   [Full Text] [Related]  

  • 31. Sublethal irradiation and syngeneic bone marrow transplant prolong thyroid xenograft survival.
    Moss AA; Almond PS; Chen SC; Fischel RJ; Salazar A; Matas AJ
    Transplant Proc; 1992 Apr; 24(2):505. PubMed ID: 1566406
    [No Abstract]   [Full Text] [Related]  

  • 32. Xenogeneic bone marrow transplantation in the hamster-to-rat model prevents rejection of subsequently grafted hamster hearts.
    Bouwman E; Scheringa M; Marquet RL
    Transplant Proc; 1996 Apr; 28(2):681-2. PubMed ID: 8623342
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
    Sykes M; Abraham VS; Harty MW; Pearson DA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1225-6. PubMed ID: 8442096
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
    Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST
    Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment of human hepatocytes in the livers of rats bearing bone marrow reconstructed with immunodeficient mouse bone marrow cells.
    Igarashi Y; Tateno C; Tanaka Y; Tachibana A; Utoh R; Kataoka M; Ohdan H; Asahara T; Yoshizato K
    Xenotransplantation; 2008; 15(4):235-45. PubMed ID: 18957046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival of xenogeneic heart grafts achieved by costimulatory blockade and transient mixed chimerism.
    Murakami M; Ito H; Harada E; Enoki T; Sykes M; Hamano K
    Transplantation; 2006 Jul; 82(2):275-81. PubMed ID: 16858292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment.
    Lee LA; Sachs DH; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1246-7. PubMed ID: 8442104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.